Annual Accounts Payable
$36.68 M
+$7.38 M+25.18%
31 December 2023
Summary:
ANI Pharmaceuticals annual accounts payable is currently $36.68 million, with the most recent change of +$7.38 million (+25.18%) on 31 December 2023. During the last 3 years, it has risen by +$25.42 million (+225.75%). ANIP annual accounts payable is now at all-time high.ANIP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$60.89 M
+$12.21 M+25.08%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly accounts payable is currently $60.89 million, with the most recent change of +$12.21 million (+25.08%) on 30 September 2024. Over the past year, it has increased by +$26.81 million (+78.68%). ANIP quarterly accounts payable is now at all-time high.ANIP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.2% | +78.7% |
| 3 y3 years | +225.8% | +428.9% |
| 5 y5 years | +312.9% | +455.9% |
ANIP Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +225.8% | at high | +428.9% |
| 5 y | 5 years | at high | +312.9% | at high | +455.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ANI Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $60.89 M(+25.1%) |
| June 2024 | - | $48.68 M(-1.5%) |
| Mar 2024 | - | $49.43 M(+34.7%) |
| Dec 2023 | $36.68 M(+25.2%) | $36.68 M(+7.6%) |
| Sept 2023 | - | $34.08 M(+19.5%) |
| June 2023 | - | $28.50 M(-12.8%) |
| Mar 2023 | - | $32.69 M(+11.5%) |
| Dec 2022 | $29.30 M(+27.6%) | $29.30 M(+54.3%) |
| Sept 2022 | - | $18.99 M(-31.3%) |
| June 2022 | - | $27.64 M(+25.3%) |
| Mar 2022 | - | $22.06 M(-4.0%) |
| Dec 2021 | $22.97 M(+104.0%) | $22.97 M(+99.5%) |
| Sept 2021 | - | $11.51 M(-11.3%) |
| June 2021 | - | $12.98 M(-5.8%) |
| Mar 2021 | - | $13.77 M(+22.3%) |
| Dec 2020 | $11.26 M(-22.9%) | $11.26 M(-16.3%) |
| Sept 2020 | - | $13.46 M(-5.3%) |
| June 2020 | - | $14.21 M(+13.8%) |
| Mar 2020 | - | $12.48 M(-14.5%) |
| Dec 2019 | $14.61 M(+64.4%) | $14.61 M(+33.4%) |
| Sept 2019 | - | $10.95 M(+11.7%) |
| June 2019 | - | $9.81 M(-6.7%) |
| Mar 2019 | - | $10.52 M(+18.4%) |
| Dec 2018 | $8.88 M(+144.7%) | $8.88 M(+22.4%) |
| Sept 2018 | - | $7.26 M(-8.7%) |
| June 2018 | - | $7.95 M(+62.7%) |
| Mar 2018 | - | $4.89 M(+34.6%) |
| Dec 2017 | $3.63 M(+7.1%) | $3.63 M(-37.6%) |
| Sept 2017 | - | $5.82 M(+84.6%) |
| June 2017 | - | $3.15 M(-34.1%) |
| Mar 2017 | - | $4.79 M(+41.2%) |
| Dec 2016 | $3.39 M(+64.0%) | $3.39 M(-28.4%) |
| Sept 2016 | - | $4.73 M(-4.7%) |
| June 2016 | - | $4.96 M(+63.2%) |
| Mar 2016 | - | $3.04 M(+47.1%) |
| Dec 2015 | $2.07 M(-22.2%) | $2.07 M(-21.5%) |
| Sept 2015 | - | $2.63 M(+98.7%) |
| June 2015 | - | $1.32 M(-42.1%) |
| Mar 2015 | - | $2.29 M(-13.8%) |
| Dec 2014 | $2.65 M(+85.7%) | $2.65 M(-13.2%) |
| Sept 2014 | - | $3.06 M(+76.7%) |
| June 2014 | - | $1.73 M(-34.9%) |
| Mar 2014 | - | $2.66 M(+86.1%) |
| Dec 2013 | $1.43 M(+26.6%) | $1.43 M(-31.5%) |
| Sept 2013 | - | $2.09 M(+27.6%) |
| June 2013 | - | $1.63 M(+894.4%) |
| Mar 2013 | - | $164.40 K(-85.4%) |
| Dec 2012 | $1.13 M | $1.13 M(-43.7%) |
| Sept 2012 | - | $2.00 M(-47.7%) |
| June 2012 | - | $3.84 M(+16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $3.28 M(+4.2%) |
| Dec 2011 | $3.15 M(-35.2%) | $3.15 M(-47.9%) |
| Sept 2011 | - | $6.04 M(-4.8%) |
| June 2011 | - | $6.35 M(-25.3%) |
| Mar 2011 | - | $8.50 M(+74.8%) |
| Dec 2010 | $4.86 M(+99.3%) | $4.86 M(+7.5%) |
| Sept 2010 | - | $4.52 M(-4.2%) |
| June 2010 | - | $4.72 M(+17.9%) |
| Mar 2010 | - | $4.00 M(+64.0%) |
| Dec 2009 | $2.44 M(-23.3%) | $2.44 M(-30.9%) |
| Sept 2009 | - | $3.53 M(+38.4%) |
| June 2009 | - | $2.55 M(+5.0%) |
| Mar 2009 | - | $2.43 M(-23.7%) |
| Dec 2008 | $3.18 M(+347.8%) | $3.18 M(-7.0%) |
| Sept 2008 | - | $3.42 M(+30.5%) |
| June 2008 | - | $2.62 M(+13.8%) |
| Mar 2008 | - | $2.30 M(+223.8%) |
| Dec 2007 | $710.60 K(+14.3%) | $710.60 K(+27.0%) |
| Sept 2007 | - | $559.40 K(-37.1%) |
| June 2007 | - | $888.80 K(+38.1%) |
| Mar 2007 | - | $643.80 K(+3.5%) |
| Dec 2006 | $621.80 K(-45.4%) | $621.80 K(+95.4%) |
| Sept 2006 | - | $318.30 K(-52.5%) |
| June 2006 | - | $669.70 K(-51.5%) |
| Mar 2006 | - | $1.38 M(+21.1%) |
| Dec 2005 | $1.14 M(-2.5%) | $1.14 M(+119.8%) |
| Sept 2005 | - | $518.50 K(-33.7%) |
| June 2005 | - | $782.50 K(-25.7%) |
| Mar 2005 | - | $1.05 M(-9.9%) |
| Dec 2004 | $1.17 M(+389.7%) | $1.17 M(+36.5%) |
| Sept 2004 | - | $856.10 K(+40.7%) |
| June 2004 | - | $608.30 K(+61.9%) |
| Mar 2004 | - | $375.80 K(+57.4%) |
| Dec 2003 | $238.70 K(-49.3%) | $238.70 K(-12.1%) |
| Sept 2003 | - | $271.70 K(-43.3%) |
| June 2003 | - | $478.80 K(+93.2%) |
| Mar 2003 | - | $247.80 K(-47.4%) |
| Dec 2002 | $470.90 K(+419.2%) | $470.90 K(-10.9%) |
| Sept 2002 | - | $528.70 K(+84.1%) |
| June 2002 | - | $287.20 K(+101.5%) |
| Mar 2002 | - | $142.50 K(+57.1%) |
| Dec 2001 | $90.70 K(+102.9%) | $90.70 K(-9.3%) |
| Sept 2001 | - | $100.00 K(-48.4%) |
| June 2001 | - | $193.70 K(+108.1%) |
| Mar 2001 | - | $93.10 K(+108.3%) |
| Dec 2000 | $44.70 K(-41.3%) | $44.70 K(-34.2%) |
| Sept 2000 | - | $67.90 K(-38.8%) |
| June 2000 | - | $111.00 K(+10.0%) |
| Mar 2000 | - | $100.90 K |
| Dec 1999 | $76.10 K(+10.6%) | - |
| Dec 1998 | $68.80 K | - |
FAQ
- What is ANI Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual accounts payable year-on-year change?
- What is ANI Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly accounts payable year-on-year change?
What is ANI Pharmaceuticals annual accounts payable?
The current annual accounts payable of ANIP is $36.68 M
What is the all time high annual accounts payable for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual accounts payable is $36.68 M
What is ANI Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ANIP annual accounts payable has changed by +$7.38 M (+25.18%)
What is ANI Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ANIP is $60.89 M
What is the all time high quarterly accounts payable for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly accounts payable is $60.89 M
What is ANI Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ANIP quarterly accounts payable has changed by +$26.81 M (+78.68%)